This is a community-generated profile. If you would like to claim it, please .
Arch Therapeutics Funding
$3.3M
33 rounds
Arch Therapeutics is active in the following markets / industries: biotechnology. The company has secured funding across 3 rounds, totaling in an amount of $3.3M. Their most recent funding was raised on February 7, 2014.
Funding Rounds
U
$2900000U
$370400U
$75000Investors of Arch Therapeutics
Chief Financial Officer and Board Member of zPREDICTA. Angel investor in software, life sciences and education. Former investment banker. MIT Sloan MBA. Irish.
Jared Mitchell
Partner at Aisling Ventures, Jared makes direct investments in companies with concrete management teams building scalable businesses.